Maternal obesity alters uterine NK activity through a functional KIR2DL1/S1 imbalance

Immunol Cell Biol. 2018 Sep;96(8):805-819. doi: 10.1111/imcb.12041. Epub 2018 Apr 16.

Abstract

In pregnancy, uterine natural killer cells (uNK) play essential roles in coordinating uterine angiogenesis, blood vessel remodeling and promoting maternal tolerance to fetal tissue. Deviances from a normal uterine microenvironment are thought to modify uNK function(s) by limiting their ability to establish a healthy pregnancy. While maternal obesity has become a major health concern due to associations with adverse effects on fetal and maternal health, our understanding into how obesity contributes to poor pregnancy disorders is unknown. Given the importance of uNK in pregnancy, this study examines the impact of obesity on uNK function in women in early pregnancy. We identify that uNK from obese women show a greater propensity for cellular activation, but this difference does not translate into increased effector killing potential. Instead, uNK from obese women express an altered repertoire of natural killer receptors, including an imbalance in inhibitory KIR2DL1 and activating KIR2DS1 receptors that favors HLA-C2-directed uNK activation. Notably, we show that obesity-related KIR2DS1 skewing potentiates TNFα production upon receptor crosslinking. Together, these findings suggest that maternal obesity modifies uNK activity by altering the response toward HLA-C2 antigen and KIR2DL1/2DS1-controlled TNFα release. Furthermore, this work identifies alterations in uNK function resulting from maternal obesity that may impact early developmental processes important in pregnancy health.

Keywords: Decidua; killer immunoglobulin-like receptor; natural killer cell; obesity; pregnancy; uterus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cohort Studies
  • Cytotoxicity, Immunologic
  • Decidua / cytology
  • Female
  • HLA-C Antigens / metabolism
  • Humans
  • Killer Cells, Natural / immunology*
  • Lymphocyte Activation
  • Maternal Exposure / adverse effects
  • Obesity / immunology*
  • Pregnancy
  • Receptors, KIR / metabolism*
  • Receptors, KIR2DL1 / metabolism*
  • Tumor Necrosis Factor-alpha / metabolism
  • Uterus / immunology*
  • Young Adult

Substances

  • HLA-C Antigens
  • HLA-C*02 antigen
  • KIR2DL1 protein, human
  • KIR2DS1 protein, human
  • Receptors, KIR
  • Receptors, KIR2DL1
  • Tumor Necrosis Factor-alpha